Drugs / Methadon
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07092475 | Nov 2025 | breast cancer, substance-related disorder | University of Utah | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Methadon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07092475 ↗ |
| Route | Intravenous | “a single dose of intravenous methadone administered within 30 minutes after induction of anesthesia” NCT07092475 ↗ |